Bio-Gene Technology and Envu collaboration for mosquito management evaluation

Bio-Gene Technology Limited (ASX: $BGT) and Envu are collaborating to evaluate Flavocide™ for use in professional pest management and public health products to control mosquitoes. The joint collaboration aims to assess the effectiveness of Flavocide™ across various professional applications, complementing Envu's product pipeline for the global professional non-crop market.

Executive commentary on the collaboration

Tim Grogan, Managing Director & Chief Executive Officer for Bio-Gene, expressed, 'Our work with Envu extends the potential for Flavocide to be used in major professional pest management and public health target markets worldwide for the control of mosquitoes.' Bernard Jacqmin, Senior Vice President - Head of Global Innovation for Envu, added, 'Flavocide is derived from nature and has demonstrated a favorable profile to combat mosquitoes. Our combined efforts are already showing promising results in the testing phase, and we are excited about the potential benefits for consumers and professionals in the field.'

Summary of the collaboration and outlook

Bio-Gene Technology and Envu's collaboration aims to evaluate Flavocide™ for mosquito management applications, leveraging the nature-positive innovation commitment of Envu. Flavocide™, a nature-identical compound, complements Envu's professional pest and mosquito management product portfolios. The collaboration combines Bio-Gene's discovery and development pipeline with Envu's formulation expertise to maximize efficacy and application efficiency. The evaluation of Flavocide™ has shown promising results, indicating potential benefits for consumers and professionals in the field. Bio-Gene's ambition to address insecticide resistance and toxicity aligns with the collaboration's goal to provide effective and safe pest management solutions. The future development or licensing agreements for Flavocide™ will be jointly announced by Bio-Gene and Envu, reflecting the ongoing exploration of opportunities for commercial use.